Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · IEX Real-Time Price · USD
0.504
+0.011 (2.17%)
At close: Jul 19, 2024, 4:00 PM
0.503
-0.001 (-0.14%)
Pre-market: Jul 22, 2024, 6:06 AM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $37.79 million as of July 22, 2024. Its market cap has decreased by -11.09% in one year.
Market Cap
37.79M
Enterprise Value
-64.68M
1-Year Change
-11.09%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $37.79M, a decrease of -93.17%. That is a compound annual growth rate of -51.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 39.40M | -20.88% |
| Dec 29, 2023 | 49.80M | 22.06% |
| Dec 30, 2022 | 40.80M | -91.94% |
| Dec 31, 2021 | 505.90M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.48% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 38.45M |
| Curis | 38.25M |
| Concord Medical Services Holdings | 38.22M |
| Ocean Biomedical | 38.11M |
| Mobile-health Network Solutions | 38.08M |
| Cue Biopharma | 37.03M |
| IN8bio | 36.62M |
| Precision Optics Corporation | 36.32M |